Brawn Biotech Ltd

Brawn Biotech Ltd

Brawn Biotech Ltd has announced the appointment of M/s. GDSM and Co. as its statutory auditors and the re-appointment of Mr. Brij Raj Gupta as a director, both of which were approved by the company's members.

Brawn Biotech Ltd

Brawn Biotech Ltd has announced the voting results and scrutinizer's report for its 41st Annual General Meeting (AGM) held on September 29, 2026, through video conferencing. All items of business were approved by the members, and the details of voting results are enclosed in the prescribed format.

Brawn Biotech Ltd

Brawn Biotech Ltd held its 41st Annual General Meeting (AGM) on September 29, 2026, through video conferencing. The meeting was attended by 44 members, and the resolutions related to audited financial statements, director appointment, statutory auditor appointment, and managerial remuneration were passed.

Brawn Biotech Ltd

Brawn Biotech Ltd held its 41st Annual General Meeting on September 29, 2026, through VC/OAVM, and all resolutions were passed with a requisite majority.

Brawn Biotech Ltd

Brawn Biotech Ltd has announced the closure of its trading window for insiders from October 1, 2026, until 48 hours after the declaration of un-audited financial results for the quarter and half year ended September 30, 2026.

Brawn Biotech Ltd

Brawn Biotech Ltd has issued letters to shareholders who have not registered their email address, providing a weblink for accessing the Notice of the 41st Annual General Meeting and Annual Report for the financial year 2025-26.

Brawn Biotech Ltd

Brawn Biotech Ltd has published a newspaper advertisement for its 41st Annual General Meeting (AGM) to be held on September 29, 2026, through video conferencing. The company has also been involved in a copyright dispute related to an AI-generated artwork, with the Copyright Office rejecting the application for registration of the artwork as the AI system, DABUS, is not recognized as the legal author under Indian copyright law.

Brawn Biotech Ltd

Brawn Biotech Ltd has released its annual report for FY 2025-26, along with the notice of its 41st Annual General Meeting. The meeting will be held on September 29, 2026, through video conferencing. The report includes the audited financial statements, directors' report, and other relevant information.

Brawn Biotech Ltd

Brawn Biotech Ltd has announced the notice of its 41st Annual General Meeting (AGM) to be held on 29th September 2026. The meeting will consider the audited financial statements for the financial year ended 31st March 2026, appointment of a director, and managerial remuneration of Mr. Amit Kumar.

Brawn Biotech Ltd

Brawn Biotech Ltd has published its un-audited financial results for the quarter ended June 30, 2026, in compliance with Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements), 2015.

Brawn Biotech Ltd

Brawn Biotech Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, which were approved by the Board of Directors in a meeting held on August 13, 2026. The company reported revenue from operations of ₹ 217.18 crore, a decrease of 0.53% from the previous quarter. The net profit for the quarter stood at ₹ 4.05 crore, a decrease of 56.25% from the previous quarter.

Brawn Biotech Ltd

Brawn Biotech Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹ 217.18 crore and profit before tax at ₹ 4.15 crore. The company's board of directors has approved the financial results and also considered and approved the Boards' Report for the financial year ended March 31, 2026.

Brawn Biotech Ltd

Brawn Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve Un-Audited Financial Results for the quarter ended June 30, 2026.